标题
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2017, Issue -, Pages 1-21
出版商
Hindawi Limited
发表日期
2017-11-03
DOI
10.1155/2017/9673537
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo
- (2017) Jie Ye et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate
- (2017) Rebeca Kawahara et al. Journal of Proteomics
- Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling
- (2017) Adam Graham Grieve et al. eLife
- Clinical benefit of INCB7839, a potent and selective ADAM inhibitor, in combination with trastuzumab in patients with metastatic HER2+ breast cancer.
- (2017) R. C. Newton et al. JOURNAL OF CLINICAL ONCOLOGY
- Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy
- (2016) Ivana Vidlickova et al. BMC CANCER
- v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1
- (2016) Xiaoming Ju et al. CANCER RESEARCH
- A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections
- (2016) Narges Seyfizadeh et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin IINovelty and Significance
- (2016) Takehiko Takayanagi et al. HYPERTENSION
- Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17
- (2016) Manuel Franke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular basis for the mechanism of action of an anti-TACE antibody
- (2016) Li Peng et al. mAbs
- Syndecan 4 Mediates Nrf2-dependent Expansion of Bronchiolar Progenitors That Protect Against Lung Inflammation
- (2016) Arif Santoso et al. MOLECULAR THERAPY
- MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation
- (2016) Bishuang Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis
- (2016) Morten Aagaard Nielsen et al. RHEUMATOLOGY
- Phosphatidylserine exposure is required for ADAM17 sheddase function
- (2016) Anselm Sommer et al. Nature Communications
- Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
- (2016) M. A. Miller et al. Cancer Discovery
- ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
- (2016) Eva A. Ebbing et al. Oncotarget
- Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
- (2016) Eitan Wong et al. Scientific Reports
- Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets
- (2016) Shinji Hirata et al. Stem Cells Translational Medicine
- TIM-3 Regulates Distinct Functions in Macrophages
- (2016) Ranferi Ocaña-Guzman et al. Frontiers in Immunology
- ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets
- (2015) Daniela Dreymueller et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression
- (2015) Junhua Wei et al. BIOMEDICINE & PHARMACOTHERAPY
- LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2
- (2015) Baohui Liu et al. BRAIN RESEARCH
- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- Role of CD154 in cancer pathogenesis and immunotherapy
- (2015) Ghada S. Hassan et al. CANCER TREATMENT REVIEWS
- Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17
- (2015) Tim M. Wanger et al. CELLULAR SIGNALLING
- A metal-based tumour necrosis factor-alpha converting enzyme inhibitor
- (2015) Chung-Hang Leung et al. CHEMICAL COMMUNICATIONS
- ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface
- (2015) Shinichi Uchikawa et al. CYTOKINE
- Inhibition of 4-1BBL-regulated TLR response in macrophages ameliorates endotoxin-induced sepsis in mice
- (2015) Bo Ram Bang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Interaction of Protein-tyrosine Phosphatase α (PTPα) and RACK1 Protein Enables Insulin-like Growth Factor 1 (IGF-1)-stimulated Abl-dependent and -independent Tyrosine Phosphorylation of PTPα
- (2015) Ranvikram S. Khanna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes
- (2015) Masakazu Kawaguchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis
- (2015) Bin-Zhi Qian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes
- (2015) Anna M. Knapinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
- (2015) J. Rios-Doria et al. MOLECULAR CANCER THERAPEUTICS
- Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling
- (2015) E Sanchez-Lopez et al. ONCOGENE
- Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin
- (2015) ZEJUN YAN et al. ONCOLOGY REPORTS
- iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
- (2015) Xue Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes
- (2015) F. Ren et al. TISSUE ANTIGENS
- Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation
- (2015) Tobias Polte et al. Nature Communications
- 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity
- (2015) Todd Bartkowiak et al. Frontiers in Oncology
- ADAM10 and ADAM17: New Players in Trastuzumab Resistance
- (2015) Michael J. Duffy et al. Oncotarget
- Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
- (2014) X Wang et al. BRITISH JOURNAL OF CANCER
- Inhibition of Neogenin Dampens Hepatic Ischemia-Reperfusion Injury
- (2014) Martin Schlegel et al. CRITICAL CARE MEDICINE
- Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease
- (2014) D. Bilbao et al. EMBO Molecular Medicine
- P95 HER2 fragments and breast cancer outcome
- (2014) Deniz Tural et al. Expert Review of Anticancer Therapy
- Targeting the Sheddase Activity of ADAM17 by an Anti-ADAM17 Antibody D1(A12) Inhibits Head and Neck Squamous Cell Carcinoma Cell Proliferation and Motility via Blockage of Bradykinin Induced HERs Transactivation
- (2014) Yanchao Huang et al. International Journal of Biological Sciences
- Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
- (2014) P. Boutet et al. JOURNAL OF IMMUNOLOGY
- The Role of Metalloproteinase ADAM17 in Regulating ICOS Ligand–Mediated Humoral Immune Responses
- (2014) Joanna Marczynska et al. JOURNAL OF IMMUNOLOGY
- Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
- (2014) Sherif A. Ibrahim et al. PLoS One
- Metalloproteinase-Dependent TLR2 Ectodomain Shedding is Involved in Soluble Toll-Like Receptor 2 (sTLR2) Production
- (2014) Patricia Langjahr et al. PLoS One
- N-Terminal Cleavage and Release of the Ectodomain of Flt1 Is Mediated via ADAM10 and ADAM 17 and Regulated by VEGFR2 and the Flt1 Intracellular Domain
- (2014) Nandita S. Raikwar et al. PLoS One
- Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
- (2014) Hang Fai Kwok et al. PROTEIN ENGINEERING DESIGN & SELECTION
- ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer
- (2014) Sandra Van Schaeybroeck et al. Cell Reports
- The Notch ligand Jagged1 as a target for anti-tumor therapy
- (2014) Demin Li Frontiers in Oncology
- Jagged-1 juxtamembrane region: Biochemical characterization and cleavage by ADAM17 (TACE) catalytic domain
- (2013) Maristella Coglievina et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
- (2013) Jia Lu et al. CANCER CELL
- Molecular Pathways: MERTK Signaling in Cancer
- (2013) C. T. Cummings et al. CLINICAL CANCER RESEARCH
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- A novel human Fab antibody for Trop2 inhibits breast cancer growthin vitroandin vivo
- (2013) Hong Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates
- (2013) Roma Stawikowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD154 Is Released from T-cells by a Disintegrin and Metalloproteinase Domain-containing Protein 10 (ADAM10) and ADAM17 in a CD40 Protein-dependent Manner
- (2013) Daniel Yacoub et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)
- (2013) Katja Möller-Hackbarth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis
- (2013) Takahiro Nakamura et al. JOURNAL OF CLINICAL INVESTIGATION
- MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
- (2013) Rebecca S. Cook et al. JOURNAL OF CLINICAL INVESTIGATION
- iRHOM2 is a critical pathogenic mediator of inflammatory arthritis
- (2013) Priya Darshinee A. Issuree et al. JOURNAL OF CLINICAL INVESTIGATION
- ADAM17-Mediated Shedding of Fc RIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with Activation
- (2013) L. Lajoie et al. JOURNAL OF IMMUNOLOGY
- Dual Cleavage of Neuregulin 1 Type III by BACE1 and ADAM17 Liberates Its EGF-Like Domain and Allows Paracrine Signaling
- (2013) D. Fleck et al. JOURNAL OF NEUROSCIENCE
- ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway
- (2013) Xiang-jun Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Klotho Acts as a Tumor Suppressor in Cancers
- (2013) Biao Xie et al. PATHOLOGY & ONCOLOGY RESEARCH
- iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
- (2013) T. Maretzky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways
- (2013) M. Dang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Syndecan-4 Regulates Early Neutrophil Migration and Pulmonary Inflammation in Response to Lipopolysaccharide
- (2012) Yoshinori Tanino et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
- (2012) Hazel Tye et al. CANCER CELL
- Ectodomain shedding and ADAMs in development
- (2012) S. Weber et al. DEVELOPMENT
- Proteolytic processing of the protein tyrosine phosphatase α extracellular domain is mediated by ADAM17/TACE
- (2012) Katja Kapp et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates
- (2012) Dmitriy Minond et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Self-Control of HGF Regulation on Human Trophoblast Cell Invasion via Enhancing c-Met Receptor Shedding by ADAM10 and ADAM17
- (2012) Yanyan Yang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Toll-Like Receptors in Wound Healing: Location, Accessibility, and Timing
- (2012) Mohan R. Dasu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inflammatory Bowel Disease andADAM17Deletion
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Upregulation of Trop-2 quantitatively stimulates human cancer growth
- (2012) M Trerotola et al. ONCOGENE
- The Axonal Guidance Receptor Neogenin Promotes Acute Inflammation
- (2012) Klemens König et al. PLoS One
- Nuclear Targeting of IGF-1 Receptor in Orbital Fibroblasts from Graves' Disease: Apparent Role of ADAM17
- (2012) Neil Hoa et al. PLoS One
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE
- (2012) C. Adrain et al. SCIENCE
- Platelet GPVI: a target for antithrombotic therapy?!
- (2012) Sebastian Dütting et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Minireview: IGF, Insulin, and Cancer
- (2011) Emily J. Gallagher et al. ENDOCRINOLOGY
- The guidance receptor neogenin promotes pulmonary inflammation during lung injury
- (2011) Valbona Mirakaj et al. FASEB JOURNAL
- Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)
- (2011) Edward Thorp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Fc RI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy
- (2011) J. E. Bakema et al. JOURNAL OF IMMUNOLOGY
- The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity
- (2011) J E Bakema et al. Mucosal Immunology
- TACE cleaves neogenin to desensitize cortical neurons to the repulsive guidance molecule
- (2011) Yusuke Okamura et al. NEUROSCIENCE RESEARCH
- Inflammatory Skin and Bowel Disease Linked toADAM17Deletion
- (2011) Diana C. Blaydon et al. NEW ENGLAND JOURNAL OF MEDICINE
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-domain inhibition of TACE ectodomain
- (2011) C. J. Tape et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases
- (2010) M. Bender et al. BLOOD
- ADAM-17: A Target to Increase Chemotherapeutic Efficacy in Colorectal Cancer?
- (2010) A. M. Lee et al. CLINICAL CANCER RESEARCH
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Clinical relevance of microparticles from platelets and megakaryocytes
- (2010) Joseph E Italiano et al. CURRENT OPINION IN HEMATOLOGY
- Lymphotoxin-αβ heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis
- (2010) Judy Young et al. CYTOKINE
- Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1
- (2010) Wei Yi et al. EXPERIMENTAL CELL RESEARCH
- Ectodomain shedding of Fcα receptor is mediated by ADAM10 and ADAM17
- (2010) Min Peng et al. IMMUNOLOGY
- A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor
- (2010) Florian Schelter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site
- (2010) S. M. Le Gall et al. JOURNAL OF CELL SCIENCE
- ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin
- (2010) J Malapeira et al. ONCOGENE
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
- (2010) E. Boilard et al. SCIENCE
- The proliferating role of insulin and insulin-like growth factors in cancer
- (2010) Emily Jane Gallagher et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition
- (2009) David M. Burns et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety
- (2009) Yun-Long Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Sdc1 negatively modulates carcinoma cell motility and invasion
- (2009) Tohru Ishikawa et al. EXPERIMENTAL CELL RESEARCH
- The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding
- (2009) Toshihiko Hoashi et al. FASEB JOURNAL
- The Study of the Inhibition of the Recombinant TACE Prodomain to Endotoxemia in Mice
- (2009) Xiaoou Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and -4 by Lung Epithelial Cells
- (2009) Jessica Pruessmeyer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury
- (2009) Jaklien C. Leemans et al. PLoS One
- Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
- (2008) L. Witters et al. CANCER RESEARCH
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- Neuregulins and Cancer
- (2008) J. C. Montero et al. CLINICAL CANCER RESEARCH
- Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohnʼs disease risk in a population-based case-control study: Evidence of gene–gene interactions
- (2008) Toshihiko Okazaki et al. INFLAMMATORY BOWEL DISEASES
- MicroRNAmiR-199a*Regulates theMETProto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)
- (2008) Seonhoe Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
- (2008) Takuma Aikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- The ADAM metalloproteinases
- (2008) D EDWARDS et al. MOLECULAR ASPECTS OF MEDICINE
- The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer
- (2008) Jessica Pruessmeyer et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
- (2008) Marcia L Moss et al. Nature clinical practice. Rheumatology
- Design and identification of selective HER-2 sheddase inhibitors via P1′ manipulation and unconventional P2′ perturbations to induce a molecular metamorphosis
- (2007) Wenqing Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle permutations
- (2007) David M. Burns et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started